SEC 13F Intelligence

Endurant Capital Management LP / EW

Endurant Capital Management LP’s Edwards Lifesciences Corp Position

Does Endurant Capital Management LP own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 44.6K shares worth $5M in Q1 2022; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$5M
Q1 2022
Shares
44.6K
% of Portfolio
+1.38%
Quarters Held
1
position exited

Position History EW

Reported value by quarter
Q1 ’22: $5MQ1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202244.6K$5M+1.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of EW.